The US Department of Health and Human Services (HHS) has released final guidance for the second cycle of Medicare drug price negotiations. 3 October 2024
The Russian government has finalized the rules for granting preference to domestic drugs in public procurements, which will come into force in 2025. 1 October 2024
The Danish government is to remove the rules that currently prohibit the purchase of medicines from countries outside the European Union (EU) in a move that has not been welcomed by pharma. 30 September 2024
India is set to complete 50 new greenfield pharma manufacturing plants in the next two years under its Production-linked Incentive (PLI) scheme for pharma and medical devices. 30 September 2024
Global leaders have approved a political declaration at the 79th United Nations General Assembly (UNGA) High-Level Meeting on Antimicrobial Resistance (AMR). 30 September 2024
The generics and biosimilars trade group, Medicines for Europe, has put out a strong message amid ongoing discussions on a European Union (EU) Critical Medicines Act. 26 September 2024
US biotech Emergent BioSolutions revealed it has secured approximately $400 million in orders in 2024 and 2025 associated with its vaccinia, smallpox and mpox product portfolio. 26 September 2024
The UK government has released a position paper outlining its vision for Framework Programme 10 (FP10), a successor to Horizon Europe, the EU's flagship research collaboration program. 26 September 2024
President Biden has said the USA will commit at least $500 million to support African countries in battling the ongoing mpox outbreak in Central and Eastern Africa. 25 September 2024
The Pharmaceutical Research and Manufacturers of America (PhRMA) is continuing its legal challenge against the US government’s drug pricing reforms. 24 September 2024
The Foundation for Economic and Industrial Research and Greek pharma trade group the Hellenic Association of Pharmaceutical Companies have presented two studies reflecting the industry’s importance. 23 September 2024
Basilea Pharmaceutica announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) has awarded Basilea an Other Transaction Agreement (OTA), under OTA number 75A50124C00033. 20 September 2024
Novo Nordisk is under increasing pressure over the cost of its blockbuster drugs in the USA, as chief executive Lars Fruergaard Jørgensen prepares to testify before a powerful Senate committee. 18 September 2024
The research based pharmaceutical industry has welcomed Mario Draghi’s report, published by the European Commission, outlining proposals on how Europe can regain its competitive edge and the critical role of innovative industries in achieving this. 11 September 2024
Even as emerging signs of a thaw in the broader Indian start-up funding landscape were evident, the Competition Commission of India (CCI) has tightened its exemption list under new combination rules. 11 September 2024
The US House of Representatives has passed the BIOSECURE Act, gaining bipartisan support with a vote of 306–81. Nearly all of the votes against the bill came from Democrats. 10 September 2024
The Cell and Gene Therapy Catapult (CGT Catapult) has highlighted what it regards as the UK's potential to lead the global cell and gene therapy sector. 5 September 2024
The budget on October 30 is an opportunity to end short-termism, cut waste, and attract long-term investment to the country’s economy with a sector-targeted R&D tax relief policy, according to the UK BioIndustry Association (BIA). 3 September 2024
The Danish Pharmaceutical Industry Association, Lif, has given its verdict on the government financial bill setting out new priorities in health in 2025. 2 September 2024
Marseille-based ImCheck Therapeutics has received 20.2 million euros ($22.4 million) in non-dilutive funding as part of the i-Démo call for projects under the France 2030 Plan operated by Bpifrance on behalf of the French government. 29 August 2024
On Thursday, The Pharma Letter reported that privately-held biotech startup Immunochina had become the latest Chinese venture to attract overseas investment as it raised 50 million renminbi ($7.5 million) in a funding round. 24 November 2017
While many in the UK life sciences sector have looked on with concern as Brexit-backing Conservatives have pushed the nation towards exiting the European Union (EU) without even agreeing a deal with the trade bloc, the government’s promises over the past year for funding for science and health have been widely welcomed by the industry. 22 November 2017
European heads of state have chosen Amsterdam as the new home for the European Medicines Agency post-Brexit, simultaneously ending months of speculation and the hopes of 18 other nations bidding to host the prestigious organization. 21 November 2017
If Health Canada achieves its goal of lowering the maximum prices for drugs, the health of Canadians could suffer, shows a Viewpoint published today by the Montreal Economic Institute (MEI), an independent, non-partisan, not-for-profit research and educational organization. 15 November 2017
Announcing his pick for the next Health and Human Services (HHS) Secretary in a Tweet on Monday, US President Donald Trump returned to the rhetoric of his sporadic outbursts on pharmaceutical product prices once more. 14 November 2017
Following a clash with the Greek government over its decision to withdraw a cancer drug from the market, Swiss pharma giant Roche ultimately decided to make the drug available to patients for free, according to the Brussels-based think-tank Euractiv. 4 November 2017
The UK government has announced a new fast-track route into the National Health Service (NHS) for breakthrough medicines and technologies. 3 November 2017
Venezuela is one of the emerging pharmaceutical markets in South America, with a major dependence on imports. However, economic and political turmoil along with inefficient patent laws and drug pricing policies are major barriers. 3 November 2017
Michael Ellenbogen, who was diagnosed with younger-onset Alzheimer’s disease in 2008, was invited to give a talk to staff at a major pharma company last week. He has provided his speech to The Pharma Letter as part of his drive for urgent action to defeat the disease. 31 October 2017
On November 20, the question of which country will host the European Medicines Agency post-Brexit will finally be settled, at the European Council’s General Affairs (Art. 50) meeting. 25 October 2017
The US Federal Trade Commission (FTC) – alongside colleagues at the Food and Drug Administration (FDA) – is trying to gain an insight what impediments there are to fairness and competition in prescription drug markets. 19 October 2017
The past and present failings of the Chinese pharma industry have been highlighted by Bi Jingquan, the director of the China Food and Drug Administration (CFDA). 16 October 2017
Following the Republican party's failure to repeal the Affordable Care Act, US President Donald Trump went it alone Thursday, signing a heavily-trailed executive order that could scupper the legislation. 13 October 2017
The key drivers for the Indonesian pharmaceutical market are the introduction of 15 economic policy packages to attract foreign investors, the implementation of Universal Health Coverage scheme (Jaminan Kesehatan Nasional, JKN), and growing urban population. 13 October 2017
Drug pricing, subject of impassioned presidential Tweets not so long ago, has ceded priority in recent months, amid the furore over Obamacare replacement efforts. 10 October 2017
The level of rebates and claw-backs that pharmaceutical companies in Greece are required to pay is unique by European standards and indicative of the over-taxation that is killing the industry. 9 October 2017
Yet another congressional push to repeal and replace the Affordable Care Act has failed as, for a second time, Republicans opted to withdraw proposals rather than face the humiliation of defeat. 6 October 2017
The UK High Court has rejected a bid from the the British pharma industry to prevent the National Institute for Health and Care Excellence from imposing new rules around price negotiations. 5 October 2017